Blood antibodies may predict heart failure risk after viral infection
NCT ID NCT06742008
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at whether certain antibodies in the blood can help predict which patients with acute viral myocarditis (heart inflammation caused by a virus) will go on to develop dilated cardiomyopathy (a weakened, enlarged heart). Researchers will measure two specific antibodies in 300 patients and follow them over time to see who develops heart problems. The goal is to find a way to identify high-risk patients early so they can be monitored or treated more closely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIRAL MYOCARDITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
RECRUITINGWuhan, Hubei, 430000, China